November 2023 U.S. Drug Supply Chain Security Act (DSCSA) now in effect; Tecsys WMS provides regulatory adherence and optimized healthcare distribution efficiency. MONTREAL, Nov. 27, 2023 /CNW/ -- Tecsys Inc. (TSX: TCS), a global leader in supply chain management solutions, today announced Elite™ WMS for Healthcare Distribution, a warehouse management system with embedded serialized DSCSA support designed for efficient and continuous compliance with DSCSA regulations as outlined by the U.S. Food and Drug Administration (FDA). TECSYS (PRNewsfoto/TECSYS) Tecsys' Elite WMS for Healthcare Distribution is the industry's first warehouse management system that locally maintains full inference data on the GS1 system of standards, specifically the Serial Global Trade Item Number (SGTIN) and the Serial Shipping Container Code (SSCC). In addition to ensuring efficiency of critical warehouse functions, the system features real-time compliance and streamlined workflows for receiving, putaway and fulfillment. Its unified approach eliminates the need for multiple systems to run simultaneously, avoiding dual-entry workflows. With the DSCSA mandate requiring electronic documentation of products and ownership now in effect, Elite™ WMS for Healthcare Distribution provides wholesale pharmaceutical distributors and 3PLs a market-tested solution for regulatory adherence. Trading partner readiness extends downstream to health system and retail pharmacy clients, who must ensure upstream and downstream compliance to facilitate traceability through to the point of use. "While the industry plays catch up on this functionality, Tecsys has the distinct advantage of several years of experience designing and enhancing DSCSA-driven capabilities," explained John Reichert, senior director of Supply Chain Execution at Tecsys. "This newly launched WMS offering builds on that advanced serialization foundation to provide the market a highly targeted and robust DSCSA-compliant warehouse management system." Tecsys' senior director of Pharmacy Solutions and American Society of Health System Pharmacists member Valerie Bandy, PharmD, MBA, commented, "DSCSA's regulatory requirements have been a series of moving goalposts. Tecsys Elite™ WMS navigates those evolving requirements so that organizations can drive compliance as an integrated process within their supply chain, even as those parameters change." From its involvement with the Healthcare Distribution Alliance (HDA) to its participation in DSCSA serialization seminars, Tecsys continues to invest in its healthcare and pharmacy-specific supply chain traceability platform. Elite™ WMS for Healthcare Distribution leverages Tecsys' regulatory and compliance expertise in hospital logistics, providing the highest degree of functional maturity in the industry. This integrated DSCSA serialization compliance minimizes redundant integrations and manual record checks, enabling real-time inventory reconciliation. "It's not just about avoiding non-compliance penalties," Reichert added. "It's about enhancing efficiency, ensuring the integrity of your supply chain, and ultimately delivering better service to your healthcare providers and their patients." For more information on Elite™ WMS for Healthcare Distribution, visit: http://www.tecsys.com/dscsa. About Tecsys Since our founding 40 years ago, much has changed in the realm of supply chain technology. But one thing has remained constant; by developing dynamic and innovative supply chain solutions, Tecsys has been equipping organizations for growth and competitive advantage. Serving healthcare, distribution and converging commerce industries, and spanning multiple complex, regulated and high-volume markets, Tecsys delivers warehouse management, distribution and transportation management, supply management at point of use, and retail order management, as well as complete financial management and analytics solutions. Tecsys' shares are listed on the Toronto Stock Exchange under the ticker symbol TCS. For more information on Tecsys, visit www.tecsys.com. Copyright © Tecsys Inc. 2023. All names, trademarks, products, and services mentioned are registered or unregistered trademarks of their respective owners. Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tecsys-pioneers-integrated-dscsa-serialization-compliance-with-launch-of-elite-wms-for-healthcare-distribution-301997364.html SOURCE Tecsys Inc. Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2023/27/c5987.html
Tecsys Pioneers Integrated DSCSA Serialization Compliance with Launch of Elite™ WMS for Healthcare Distribution
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...